Diamyd Medical Completes Patient Enrollment In Phase III Diamyd Vaccine Study
Diamyd Medical has completed patient recruitment in European Phase III study of the diabetes vaccine Diamyd. It is estimated that results from the study can be reported during
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.